Coronavirus disease 2019 (COVID-19): What we need to know by Javanian, Mostafa et al.
 Caspian J Intern Med 2019; 11(2): 235-236 
Coronavirus disease 2019 (COVID-19)                                                                235 
Caspian J Intern Med 2020; 11(2):235-236 
DOI: 10.22088/cjim.11.2.23  
Letter to Editor 
 
Coronavirus disease 2019 (COVID-19): What we need to know 
 
Dear Sir, 
In recent years the world has witnessed widespread 
epidemics of infections as Ebola, Zika and Severe acute 
respiratory syndrome (SARS). As the repeated alerts have 
been issued by health organizations, the World Health 
Organization (WHO) has declared a state of emergency six 
times in recent decades. It declared 2009 flu pandemic or 
swine flu, 2014 outbreak of Ebola virus in West Africa, 2014 
Polio outbreak in the Middle East, 2016 Zika epidemic in 
Latin America and the Caribbean, 2018 new case of Ebola in 
the eastern city of Goma, and 2020 novel Coronavirus in 
China.  
The identified new coronavirus, called coronavirus 
disease 2019 (COVID-19) has been first  emerged in Wuhan, 
China, in December 2019, and has now reached several other 
countries: Hong Kong, Italy, Japan, Russia, Iran, United 
States, and more than twenty other countries. There are 
currently 157,215 confirmed cases and 5,843 deaths from 
COVID-19 outbreak as of March 15, 2020. 
Coronaviruses as an RNA viruses are common in several 
species of animals. Rarely, these viruses may infect humans 
and then spread among them. It has been confirmed that 
coronaviruses have frequently made the jump from 
circulating among animals to presenting new strains to 
human. The seven coronaviruses that can infect humans, 
including NL63, HKU1, OC43, 229E, SARS, Middle East 
Respiratory Syndrome (MERS), and COVID-19 (1). 
Alongside rhinoviruses, human coronaviruses are 
responsible for the common cold and mild illness in humans 
worldwide. The incubation period of this virus remains 
unidentified. Most evidence declared that the incubation 
period could be about 5 day and 4–5 days between symptom 
onset and case detection (2). 
The infection can be completely asymptomatic, very 
severe and even fatal. Common symptoms can include: 
fever, cough, and shortness of breath. Like many other 
respiratory infections, the virus is transmitted through 
droplets from coughs and sneezes. Fecal-oral transmission 
has also been confirmed for this type of infection. The exact 
origin of this novel coronavirus remains unknown. Although, 
some documents have declared like MERS and SARS, all of 
which have their origins in bats. Some of the cases in China's 
coronavirus outbreak had linked to a seafood and live animal 
market, suggesting animal-to-person spread. Even though, 
some patients did not report any relationship with the animal 
market, indicating person-to-person spread. The contagious 
of this virus is less susceptible to other infections like 
smallpox, measles, polio, acquired immunodeficiency 
syndrome (AIDS), SARS, and influenza. On average, every 
person with COVID-19 infects 1.4 to 2.5 people (3). 
According to reports so far, a fatality rate of COVID-19 is 
2% (one case every 50 cases) that compared to SARS 
mortality (10%) and MERS (over30%) was lower (4). 
Unfortunately, no antivirals are approved for the treatment of 
neither COVID-19 infection nor vaccines available for 
prevention. Therefore, the most important way to prevent 
infection is to avoid being exposed to this virus like hand 
and respiratory hygiene. 
As we have seen, the control of such infections requires a 
global consensus given the high rate of their spread, which is 
easily transferable from one country to another. Patients' 
information should be made available to health organizations 
for making an important decision. On the other hand, 
controlling the spread of emerging and re-emerging viruses 
like COVID-19 needs serious international collaborations. 
Moreover, the serious knowledge gaps of the origin, 
epidemiology, transmission, and other aspects of illness 
should be complemented by more extensive studies. It is 
important to note, animal diseases have always been 
transmitted to humans and in fact most of the new infectious 
diseases are caused by animals. But environmental changes 
have accelerated the trend and increased urban populations 
and international travel have made these diseases grow more 
rapidly. Therefore, climate change and globalization are 
changing the way humans and animals are treated, the 
danger is likely to be greater in the future, and countries need 
to be on the alert and strengthen their public-health 
surveillance. 
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